Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor.
Patrick-Pascal StrunzMarc SchmalzingAnke HeidemeierLeo RascheHermann EinseleKlaus Martin KortümPublished in: Leukemia & lymphoma (2019)